Cite

    Casas, A., Langhauser, F., Dao, V., Guney, E., Kleikers, P., López, M., Menche, J., Barabási, A., Kleinschnitz, C., & Schmidt, H. (2015). a systems biology approach to cGMP suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys neuroprotection and increased survival. BMC pharmacology & toxicology, 16(1), 1. http://access.bl.uk/ark:/81055/vdc_100080441580.0x000693